Golimumab Subcutaneous and Oxybutynin Extended-Release Tablets
Determining the interaction of Golimumab Subcutaneous and Oxybutynin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: oxybutynin
Brand name: Ditropan XL, Anturol, Gelnique, Oxytrol
Synonyms: Oxybutynin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-Oxybutynin Gel
- Golimumab Subcutaneous-Oxybutynin Oral Solution
- Golimumab Subcutaneous-Oxybutynin Syrup
- Golimumab Subcutaneous-Oxybutynin Tablets
- Golimumab Subcutaneous-Oxybutynin transdermal
- Golimumab Subcutaneous-Oxybutynin Transdermal System
- Oxybutynin Extended-Release Tablets-GoLYTELY
- Oxybutynin Extended-Release Tablets-Gonadorelin
- Oxybutynin Extended-Release Tablets-Gonadorelin Intravenous, Injection
- Oxybutynin Extended-Release Tablets-Gonadotropin, Chorionic
- Oxybutynin Extended-Release Tablets-Gonal-F
- Oxybutynin Extended-Release Tablets-Gonal-f RFF